China’s CSRC Unveils 16 Measures to Boost Capital Market and Tech Enterprises
The China Securities Regulatory Commission (CSRC) has introduced a comprehensive set of 16 measures aimed...
SSE STAR
JJET’s IPO on STAR Market Accepted, Aims to Raise RMB 2.691 Billion for Medical Device Expansion
China-based JJET has received acceptance for its Initial Public Offering (IPO) filing on the Shanghai...
Sino Biopharmaceutical Terminates IPO Pre-Listing Process for STAR Board
Sino Biopharmaceutical Ltd (HKG: 1177) has announced the decision to terminate the pre-listing process for...
Akeso Biopharma Plans IPO on Shanghai’s STAR Market
China-based antibody developer Akeso Biopharma (HKG: 9926) announced that its board of directors has decided...
Suzhou Novoprotein Lists on Shanghai’s STAR Market for R&D Expansion
Suzhou Novoprotein Scientific Co., Ltd, a China-based provider of protein technology and application solutions, has...
Medlander Medical Technology’s IPO Raises RMB 1 billion on Shanghai’s STAR Board
Medlander Medical Technology Inc., a leading Chinese manufacturer of pelvic floor rehabilitation equipment, has completed...
United Imaging Healthcare’s STAR Listing Raises USD1.85 Billion
Shanghai-based United Imaging Healthcare (UIH) has completed an initial public offering (IPO) of 100 million...
Ribo Life Science Raises USD 40M in Series E1 Round for siRNA Drug Development
China-based Suzhou Ribo Life Science Co., Ltd reportedly raised USD 40 million in a Series...